CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 6 Months Ended |
Jun. 30, 2021 | Jun. 30, 2020 |
Operating activities: | | |
Net income | $ 142,799 | $ 68,825 |
Adjustments to reconcile net income to net cash provided by operating activities: | | |
Depreciation and amortization | 164,632 | 163,846 |
Accretion of debt premium and discount, net | (1,435) | (144) |
Deferred financing cost amortization | 3,764 | 3,619 |
Accretion of above- and below-market leases, net | (7,125) | (8,224) |
Tenant inducement amortization and other | 3,012 | 1,789 |
Impairment of real estate assets | 1,898 | 10,560 |
Gain on sale of real estate assets | (38,367) | (9,597) |
Equity based compensation | 6,791 | 4,607 |
Loss on extinguishment of debt, net | 1,229 | 10,391 |
Changes in operating assets and liabilities: | | |
Receivables, net | 8,706 | (42,672) |
Deferred charges and prepaid expenses | (13,270) | (10,552) |
Other assets | (208) | (201) |
Accounts payable, accrued expenses and other liabilities | 2,436 | (12,683) |
Net cash provided by operating activities | 274,862 | 179,564 |
Investing activities: | | |
Improvements to and investments in real estate assets | (135,253) | (158,120) |
Acquisitions of real estate assets | (66,716) | (2,020) |
Proceeds from sales of real estate assets | 99,748 | 46,633 |
Purchase of marketable securities | (7,915) | (10,733) |
Proceeds from sale of marketable securities | 9,100 | 8,219 |
Net cash used in investing activities | (101,036) | (116,021) |
Financing activities: | | |
Repayment of secured debt obligations | 0 | (7,000) |
Repayment of borrowings under unsecured revolving credit facility | 0 | (507,500) |
Proceeds from borrowings under unsecured revolving credit facility | 0 | 646,000 |
Proceeds from unsecured notes | 349,360 | 498,880 |
Repayment of borrowings under unsecured term loans | (350,000) | (182,479) |
Deferred financing and debt extinguishment costs | (3,414) | (14,049) |
Distributions to common stockholders | (129,101) | (170,397) |
Repurchases of common shares | 0 | (25,007) |
Repurchases of common shares in conjunction with equity award plans | (5,372) | (3,523) |
Net cash provided by (used in) financing activities | (138,527) | 234,925 |
Net change in cash, cash equivalents and restricted cash | 35,299 | 298,468 |
Cash, cash equivalents and restricted cash at beginning of period | 370,087 | 21,523 |
Cash, cash equivalents and restricted cash at end of period | 405,386 | 319,991 |
Reconciliation to consolidated balance sheets: | | |
Cash and cash equivalents | 404,144 | 318,540 |
Restricted cash | 1,242 | 1,451 |
Cash, cash equivalents and restricted cash at end of period | 405,386 | 319,991 |
Supplemental disclosure of cash flow information: | | |
Cash paid for interest, net of amount capitalized of $1,817 and $2,177 | 95,523 | 94,593 |
Brixmor Operating Partnership LP | | |
Operating activities: | | |
Net income | 142,799 | 68,825 |
Adjustments to reconcile net income to net cash provided by operating activities: | | |
Depreciation and amortization | 164,632 | 163,846 |
Accretion of debt premium and discount, net | (1,435) | (144) |
Deferred financing cost amortization | 3,764 | 3,619 |
Accretion of above- and below-market leases, net | (7,125) | (8,224) |
Tenant inducement amortization and other | 3,012 | 1,789 |
Impairment of real estate assets | 1,898 | 10,560 |
Gain on sale of real estate assets | (38,367) | (9,597) |
Equity based compensation | 6,791 | 4,607 |
Loss on extinguishment of debt, net | 1,229 | 10,391 |
Changes in operating assets and liabilities: | | |
Receivables, net | 8,706 | (42,672) |
Deferred charges and prepaid expenses | (13,270) | (10,552) |
Other assets | (208) | (201) |
Accounts payable, accrued expenses and other liabilities | 2,436 | (12,683) |
Net cash provided by operating activities | 274,862 | 179,564 |
Investing activities: | | |
Improvements to and investments in real estate assets | (135,253) | (158,120) |
Acquisitions of real estate assets | (66,716) | (2,020) |
Proceeds from sales of real estate assets | 99,748 | 46,633 |
Purchase of marketable securities | (7,915) | (10,733) |
Proceeds from sale of marketable securities | 9,100 | 8,219 |
Net cash used in investing activities | (101,036) | (116,021) |
Financing activities: | | |
Repayment of secured debt obligations | 0 | (7,000) |
Repayment of borrowings under unsecured revolving credit facility | 0 | (507,500) |
Proceeds from borrowings under unsecured revolving credit facility | 0 | 646,000 |
Proceeds from unsecured notes | 349,360 | 498,880 |
Repayment of borrowings under unsecured term loans | (350,000) | (182,479) |
Deferred financing and debt extinguishment costs | (3,414) | (14,049) |
Partner distributions and repurchases of OP Units | (134,473) | (208,925) |
Net cash provided by (used in) financing activities | (138,527) | 224,927 |
Net change in cash, cash equivalents and restricted cash | 35,299 | 288,470 |
Cash, cash equivalents and restricted cash at beginning of period | 360,073 | 21,507 |
Cash, cash equivalents and restricted cash at end of period | 395,372 | 309,977 |
Reconciliation to consolidated balance sheets: | | |
Cash and cash equivalents | 394,130 | 308,526 |
Restricted cash | 1,242 | 1,451 |
Cash, cash equivalents and restricted cash at end of period | 395,372 | 309,977 |
Supplemental disclosure of cash flow information: | | |
Cash paid for interest, net of amount capitalized of $1,817 and $2,177 | $ 95,523 | $ 94,593 |